|
| Press Releases |
|
 |
|
| Wednesday, December 17, 2014 |
|
|
酷派公佈与Qihoo 360建立战略性伙伴关系 |
中国领先的智能手机及移动数据一体化解决方案供应商酷派集团有限公司(「酷派」或「集团」，股份编号：2369) 昨日公佈其与中国领先的互联网公司Qihoo 360 Technology Co. Ltd.(「Qihoo 360」或「该公司」，纽约证券交易所代码：QIHU)建立战略性伙伴关系。根据该伙伴关系，Qihoo 360将以现金409.05百万美元投资于Coolpad E-Commerce Inc.(「合资公司」)的45%股权，而酷派将持有合资公司的55%股权。
more info >> |
|
|
酷派公佈與Qihoo 360建立戰略性夥伴關係 |
中國領先的智能手機及移動數據一體化解決方案供應商酷派集團有限公司(「酷派」或「集團」，股份編號：2369) 昨日公佈其與中國領先的互聯網公司Qihoo 360 Technology Co. Ltd.(「Qihoo 360」或「該公司」，紐約證券交易所代碼：QIHU)建立戰略性夥伴關係。根據該夥伴關係，Qihoo 360將以現金409.05百萬美元投資於Coolpad E-Commerce Inc.(「合資公司」)的45%股權，而酷派將持有合資公司的55%股權。
more info >> |
|
|
Coolpad Announces Strategic Partnership with Qihoo 360 |
| Coolpad Group Limited ("Coolpad" or the "Group") (stock code: 2369), China's leading provider of smartphones and integrated wireless data solutions, yesterday announced a strategic partnership with Qihoo 360 Technology Co. Ltd. ("Qihoo 360" or the "Company") more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
International Career Institute Marks 20 Years with 100 Scholarships to Support Flexible Online Study
Mar 24, 2026 07:29 HKT/SGT
|
|
|
Doubleview Gold Clarifies Preliminary Economic Assessment Results for the Hat Project; Updated Scenario B NPV Increased to C$7.27 Billion
Mar 24, 2026 04:59 HKT/SGT
|
|
|
在 2026 年 Gartner(R)《供應鏈規劃解決方案：流程工業》魔力象限(TM) 報告中，OMP 在「願景完整性」與「執行能力」兩大指標上均位居首位
Mar 23, 2026 23:15 HKT/SGT
|
|
|
在2026年Gartner(R)《供应链规划解决方案魔力象限(TM)：流程工业》报告中，OMP在“愿景完整性”和“执行能力”两项指标上均位居最高位置
Mar 23, 2026 23:15 HKT/SGT
|
|
|
OMP Positioned Highest for Both Completeness of Vision and Ability to Execute in the 2026 Gartner(R) Magic Quadrant(TM) for Supply Chain Planning Solutions: Process Industries
Mar 23, 2026 23:15 HKT/SGT
|
|
|
Wellgistics Health Inc. 簽署價值 1.05 億美元的意向書，以評估收購 Neuritek Therapeutics, Inc. 的可能性；該公司致力於開發治療神經系統及精神疾病的創新療法
Mar 23, 2026 21:05 HKT/SGT
|
|
|
Wellgistics Health Inc.签署1.05亿美元意向书，拟评估收购Neuritek Therapeutics, Inc.的可行性，后者致力于开发神经系统及精神疾病的创新疗法
Mar 23, 2026 21:05 HKT/SGT
|
|
|
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Mar 23, 2026 21:05 HKT/SGT
|
|
|
Essex Bio-Technology Reports Robust Results for FY2025, Turnover Soars 8.6% to HK$1814 million, Net Profit up 3.5% to HK$ 318.1 million, Total Dividend Increases by 16.7% to HK14 Cents per Share
Mar 23, 2026 20:51 HKT/SGT
|
|
|
億勝生物科技2025全年業績穩健 收入升8.6%至18.14億港元 淨利潤升3.5%至3.18億港元 全年股息增加16.7%至每股14港仙
Mar 23, 2026 20:37 HKT/SGT
|
|
|
GMG Launches European Sales Team; G(R) Lubricant Patent Accepted for Europe
Mar 23, 2026 20:29 HKT/SGT
|
|
|
亿胜生物科技2025全年业绩稳健 收入升8.6%至18.14亿港元 净利润升3.5%至3.18亿港元 全年股息增加16.7%至每股14港仙
Mar 23, 2026 20:13 HKT/SGT
|
|
|
Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint
Mar 23, 2026 19:59: JST
|
|
|
Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint
Mar 23, 2026 18:59 HKT/SGT
|
|
|
雲頂新耀達成艾曲帕米鼻噴霧劑資產收購協議 強化心血管領域產品佈局
Mar 23, 2026 18:59 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
